Table 3.
Oncologic outcomes after oral progestin only/ oral progestin+levonorgestrel-releasing intrauterine system (n=43)
| Outcome | Number of patients |
|---|---|
| Oral progestin only | 18 |
| Treatment response, n (%) | |
| CR | 8 (44.4) |
| PR | 1 (5.6) |
| SD | 4 (22.2) |
| PD | 5 (27.8) |
| Oral progestin+LNG-IUS | 25 |
| Treatment response, n (%) | |
| CR | 23 (92) |
| PR | 2 (8) |
| SD | 0 |
| PD | 0 |
LNG-IUS=Levonorgestrel-releasing intrauterine system; CR=Complete response; PR=Partial response; SD=Stable disease; PD=Progressive disease